Mediclinic International

  • TickerMDC
  • ISINGB00B8HX8Z88
  • ExchangeLondon Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited Kingdom

Analysts

GlobalData Department

Mediclinic International Plc (MDC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary Mediclinic International Plc (Mediclinic), formerly Al Noor Hospitals Group Plc is a healthcare service provider. The center offers services such as specialist-orientated, acute-care and multi disciplinary healthcare services. It also provides clinical services such as pre hospital emergency services, outpatient consultancy, hospital based emergency centres, highly specialised services, acute care inpatient services, nuclear medicine, radiology, laboratory and day case surgery. The center consists of 75 hospitals and 28 clinical which include more than 10600 inpatient beds and 410 ope...

1 director bought

A director at Mediclinic International bought 20,000 shares at 86.820ZAR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. ...

Jehanne Leroy

Mediclinic International - Proxy report 22/07/208

Leadership changes Danie Meintjes was replaced by Carol Van Der Merwe as CEO in June 2018. Danie Meintjes was then an Executive Director from June 2018 until August 2018 when he was appointed as a Non-Executive Director. Spire Takeover Takeover talks with Spire ended in November after Spire rejected Meclinic's bid in October. Controlling shareholder Shareholder should note that, unlike most UK companies, Mediclinic has a controlling shareholder. Remgro Ltd. owns 44.56% of the share capital. There is a relationship agreement in place whereby Remgro Ltd is entitled, for every 10% of the iss...

Matthieu DRIOL

Short term view - MEDICLINIC INTERNATIONAL PLC : The background trend is clearly bearish.

The background trend is clearly bearish. Prices are falling again, but the movement has become hesitant. The next support is at 494.10 p. The background trend would be questioned should prices rise above 569.40 p.

Valérie GASTALDY

Medium term view - MEDICLINIC INTERNATIONAL PLC : The movement goes on.

The background trend is clearly bearish. The movement goes on. The next target is at 495.40 p, then 400.67 p. Passing 710.10 p would question the continuation of the fall.

1 director bought

A director at Mediclinic International bought 20,000 shares at 86.820ZAR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. ...

GlobalData Department

Mediclinic International Plc (MDC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary Mediclinic International Plc (Mediclinic), formerly Al Noor Hospitals Group Plc is a healthcare service provider. The center offers services such as specialist-orientated, acute-care and multi disciplinary healthcare services. It also provides clinical services such as pre hospital emergency services, outpatient consultancy, hospital based emergency centres, highly specialised services, acute care inpatient services, nuclear medicine, radiology, laboratory and day case surgery. The center consists of 75 hospitals and 28 clinical which include more than 10600 inpatient beds and 410 ope...

Jehanne Leroy

Mediclinic International - Proxy report 22/07/208

Leadership changes Danie Meintjes was replaced by Carol Van Der Merwe as CEO in June 2018. Danie Meintjes was then an Executive Director from June 2018 until August 2018 when he was appointed as a Non-Executive Director. Spire Takeover Takeover talks with Spire ended in November after Spire rejected Meclinic's bid in October. Controlling shareholder Shareholder should note that, unlike most UK companies, Mediclinic has a controlling shareholder. Remgro Ltd. owns 44.56% of the share capital. There is a relationship agreement in place whereby Remgro Ltd is entitled, for every 10% of the iss...

Expert Corporate Governance Service (ECGS)

Etude l' AG du 25/07/2017

Item 3: Approve the Remuneration Policy. The changes proposed to the Remuneration Policy do not address the concerns over the alignment between pay and performance. The STI relies entirely on EBITDA in different divisions rather than using a variety of metrics that would capture different aspects of performance.  In addition, while the LTI includes relative TSR as a performance metric, 60% of the award is determined by EPS, which can potentially be manipulated by executive actions.  The Remuneration Report was only supported by 85.0% of shareholders in the previous year. Item 7: Re-elect the C...

Matthieu DRIOL

Short term view - MEDICLINIC INTERNATIONAL PLC : The background trend is clearly bearish.

The background trend is clearly bearish. Prices are falling again, but the movement has become hesitant. The next support is at 494.10 p. The background trend would be questioned should prices rise above 569.40 p.

Valérie GASTALDY

Medium term view - MEDICLINIC INTERNATIONAL PLC : The movement goes on.

The background trend is clearly bearish. The movement goes on. The next target is at 495.40 p, then 400.67 p. Passing 710.10 p would question the continuation of the fall.

Matthieu DRIOL

Analyse court terme - MEDICLINIC INTERNATIONAL PLC : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 494,10 p. La tendance de fond serait remise en cause en cas de franchissement de 569,40 p.

Valérie GASTALDY

Analyse moyen terme - MEDICLINIC INTERNATIONAL PLC : Le mouvement se poursuit.

La tendance de fond est clairement orientée à la baisse. Le mouvement se poursuit. Le prochain objectif est à 495,40 p, puis 400,67 p. Le franchissement de 710,10 p remettrait en cause la suite de la baisse.

Louis AZAIS

Short term view - MEDICLINIC INTERNATIONAL PLC : The major resistance has been reached, it causes the fall.

The trend is still bearish, the invalidation level is above 569.40 p. The target is at 455.80 p.Arguments :- The major resistance has been reached, it causes the fall.- Prices are breaking below the moving average, it is a sign of weakness.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch